| Disease Name |
ICD 11 |
Studied Tissue |
p-value |
Fold-Change |
Z-score |
|
Acute myelocytic leukaemia
|
2B33.1 |
Bone marrow |
8.41E-01
|
-1.16E-02
|
-8.46E-02 |
|
Alzheimer's disease
|
8A20 |
Entorhinal cortex |
2.87E-01
|
1.49E-02
|
4.17E-02 |
|
Asthma
|
CA23 |
Nasal and bronchial airway |
1.78E-01
|
1.51E-01
|
1.86E-01 |
|
Behcet's disease
|
4A62 |
Peripheral blood |
3.46E-01
|
-1.28E-01
|
-8.53E-01 |
|
Bipolar disorder
|
6A60-6A6Z |
Prefrontal cortex |
2.20E-01
|
4.38E-02
|
2.01E-01 |
|
Bladder cancer
|
2C94 |
Bladder tissue |
6.89E-04
|
-2.39E+00
|
-2.93E+00 |
|
Breast cancer
|
2C60-2C6Z |
Breast tissue |
3.23E-35
|
-1.35E+00
|
-1.40E+00 |
|
Colon cancer
|
2B90 |
Colon tissue |
1.06E-84
|
1.64E+00
|
2.94E+00 |
|
Diffuse large B-cell lymphoma
|
2A81 |
Tonsil tissue |
1.67E-01
|
-3.38E-01
|
-7.77E-01 |
|
Familial hypercholesterolemia
|
5C80.00 |
Peripheral blood |
8.91E-01
|
3.79E-02
|
3.42E-01 |
|
Gastric cancer
|
2B72 |
Gastric tissue |
2.08E-01
|
5.64E-01
|
9.23E-01 |
|
Glioblastopma
|
2A00.00 |
Nervous tissue |
5.52E-30
|
4.02E-02
|
7.17E-02 |
|
Head and neck cancer
|
2D42 |
Head and neck tissue |
7.14E-01
|
-2.96E-01
|
-3.23E-01 |
|
HIV-associated neurocognitive impairment
|
8A2Y-8A2Z |
White matter tissue |
4.31E-02
|
-2.79E-01
|
-6.71E-01 |
|
Idiopathic pulmonary fibrosis
|
CB03.4 |
Lung tissue |
3.09E-02
|
6.96E-01
|
1.47E+00 |
|
Interstitial cystitis
|
GC00.3 |
Bladder tissue |
4.20E-02
|
-3.92E-01
|
-2.28E+00 |
|
Ischemic stroke
|
8B11 |
Peripheral blood |
1.38E-01
|
7.03E-02
|
5.81E-01 |
|
Liver cancer
|
2C12.0 |
Liver tissue |
1.76E-33
|
-2.89E+00
|
-3.41E+00 |
|
Liver failure
|
DB99.7-DB99.8 |
Liver tissue |
3.66E-08
|
-4.51E+00
|
-1.13E+01 |
|
Lung cancer
|
2C25 |
Lung tissue |
1.83E-25
|
-8.99E-01
|
-1.36E+00 |
|
Lupus erythematosus
|
4A40 |
Whole blood |
1.26E-01
|
5.25E-02
|
1.80E-01 |
|
Major depressive disorder
|
6A70-6A7Z |
Hippocampus |
8.68E-01
|
-3.86E-02
|
-1.72E-01 |
|
Multiple myeloma
|
2A83.1 |
Bone marrow |
2.04E-02
|
-3.14E-01
|
-2.43E+00 |
|
Multiple myeloma
|
2A83.1 |
Peripheral blood |
6.88E-02
|
1.33E-01
|
8.10E-01 |
|
Multiple sclerosis
|
8A40 |
Plasmacytoid dendritic cells |
4.48E-01
|
3.66E-02
|
2.00E-01 |
|
Myelodysplastic syndrome
|
2A36-2A3Z |
Bone marrow |
2.87E-06
|
9.79E-02
|
5.03E-01 |
|
Myocardial infarction
|
BA41-BA50 |
Peripheral blood |
9.02E-01
|
-2.87E-02
|
-4.82E-02 |
|
Neuroectodermal tumour
|
2A00.11 |
Brain stem tissue |
8.20E-08
|
8.05E-01
|
2.28E+00 |
|
Non-alcoholic fatty liver disease
|
DB92 |
Liver tissue |
5.66E-01
|
-1.20E-01
|
-1.31E-01 |
|
Obesity related type 2 diabetes
|
5A11 |
Omental adipose tissue |
3.26E-01
|
-4.11E-01
|
-6.63E-01 |
|
Olive pollen allergy
|
CA08.00 |
Peripheral blood |
4.52E-02
|
1.26E-01
|
1.86E+00 |
|
Oral cancer
|
2B6E |
Oral tissue |
3.41E-01
|
4.78E-01
|
3.65E-01 |
|
Ovarian cancer
|
2C73 |
Ovarian tissue |
5.90E-02
|
-9.22E-01
|
-1.00E+00 |
|
Pancreatic cancer
|
2C10 |
Pancreas |
1.36E-01
|
-7.94E-01
|
-8.18E-01 |
|
Parkinson's disease
|
8A00.0 |
Substantia nigra tissue |
1.80E-02
|
1.93E-01
|
9.84E-01 |
|
Pituitary cancer
|
2D12 |
Pituitary tissue |
9.98E-01
|
2.79E-01
|
5.07E-01 |
|
Polycystic ovary syndrome
|
5A80.1 |
Vastus lateralis muscle |
8.32E-01
|
-1.79E-03
|
-9.06E-03 |
|
Pompe disease
|
5C51.3 |
Biceps muscle |
6.81E-01
|
-2.15E-01
|
-4.40E-01 |
|
Prostate cancer
|
2C82 |
Prostate |
3.75E-01
|
3.97E-01
|
3.73E-01 |
|
Psoriasis
|
EA90 |
Skin |
1.89E-21
|
-9.44E-01
|
-1.51E+00 |
|
Rectal cancer
|
2B92 |
Rectal colon tissue |
3.92E-01
|
1.08E-01
|
1.59E-01 |
|
Renal cancer
|
2C90-2C91 |
Kidney |
4.25E-02
|
-4.66E-01
|
-7.58E-01 |
|
Retinoblastoma
|
2D02.2 |
Uvea |
3.22E-05
|
-2.23E+00
|
-1.21E+01 |
|
Schizophrenia
|
6A20 |
Prefrontal cortex |
7.41E-01
|
-4.82E-02
|
-1.41E-01 |
|
Schizophrenia
|
6A20 |
Superior temporal cortex |
6.47E-01
|
-3.62E-02
|
-2.67E-01 |
|
Scleroderma
|
4A42.Z |
Whole blood |
8.66E-01
|
-1.17E-02
|
-6.20E-02 |
|
Seizure
|
8A60-8A6Z |
Whole blood |
9.76E-01
|
6.62E-02
|
3.23E-01 |
|
Sepsis with septic shock
|
1G41 |
Whole blood |
6.58E-03
|
4.38E-02
|
1.91E-01 |
|
Sickle cell disease
|
3A51.0-3A51.3 |
Peripheral blood |
4.23E-01
|
-5.60E-04
|
-6.20E-03 |
|
Simpson golabi behmel syndrome
|
LD2C |
Adipose tissue |
4.34E-01
|
3.78E-02
|
1.44E+00 |
|
Sjogren's syndrome
|
4A43.2 |
Salivary gland tissue |
7.27E-01
|
-3.76E-01
|
-8.12E-01 |
|
Skin cancer
|
2C30-2C3Z |
Skin |
2.73E-95
|
-2.06E+00
|
-3.07E+00 |
|
Thrombocythemia
|
3B63 |
Whole blood |
9.12E-01
|
3.80E-02
|
2.37E-01 |
|
Thrombocytopenia
|
3B64 |
Whole blood |
6.69E-01
|
8.56E-02
|
5.20E-01 |
|
Thyroid cancer
|
2D10 |
Thyroid |
2.97E-20
|
-9.69E-01
|
-1.44E+00 |
|
Tibial muscular dystrophy
|
8C75 |
Muscle tissue |
4.09E-04
|
-4.96E-01
|
-1.31E+00 |
|
Tuberous sclerosis complex
|
LD2D.2 |
Perituberal tissue |
8.12E-01
|
-1.42E-01
|
-9.98E-01 |
|
Type 2 diabetes
|
5A11 |
Liver tissue |
1.53E-01
|
1.70E-01
|
6.44E-01 |
|
Ureter cancer
|
2C92 |
Urothelium |
4.97E-01
|
-1.90E-01
|
-8.46E-01 |
|
Uterine cancer
|
2C78 |
Endometrium tissue |
2.13E-17
|
9.84E-01
|
1.21E+00 |
|
Vitiligo
|
ED63.0 |
Skin |
8.40E-01
|
-9.35E-02
|
-3.26E-01 |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
